IPO

Gujarat Kidney & Super Speciality Limited IPO

Mainboard

Offer Date: Dec 22, 2025 - Dec 24, 2025

₹ 14592 /128 Shares

22 Dec, 2025

Open Date

24 Dec, 2025

Close Date

26 Dec, 2025

Allotment Date

30 Dec, 2025

Listing Date
Gujarat Kidney & Super Speciality IPO Issue Details
  • Issue Price ₹108-114 per equity share
  • Face Value ₹2 Per Equity Share
  • Total Issue Size 2,20,00,000 shares(aggregating up to ₹250.8 crore)
  • Fresh Share 2,20,00,000 shares(aggregating up to ₹250.8 crore)
  • Listing at BSE, NSE
  • Lead Manager Nirbhay Capital Services Pvt.Ltd.
  • Registrar MUFG Intime India Pvt.Ltd.
Market Lot Size

Investors can bid for a minimum of 128 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (min) 1 128 ₹14,592
Retail(max) 13 1,664 ₹1,89,696
SHNI(min) 14 1,792 ₹2,04,288
SHNI(max) 68 8,704 ₹9,92,256
BHNI(min) 69 8,832 ₹10,06,848
Gujarat Kidney & Super Speciality IPO Reservation

Gujarat Kidney & Super Speciality IPO offers total NA shares. Out of which NA (NA%) allocated to QIB, NA (NA%) allocated to NII,NA (10%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered NA (NA%)
QIB Shares Offered NA (NA%)
NII (HNI) Shares Offered NA (NA%)
bNII > ₹10L NA (NA%)
sNII < ₹10L NA (NA%)
Retail Shares Offered NA (10%)
Total Shares Offered NA (NA%)
Gujarat Kidney & Super Speciality IPO Documents
Gujarat Kidney & Super Speciality IPO Details


Gujarat Kidney & Super Speciality IPO is a book-built issue of ₹250.8 crores, The total issue size is ₹250.8 crores. The IPO of Gujarat Kidney & Super Speciality is priced at ₹108-114 per equity share, which has a face value of ₹2 Per Equity Share each, IPO bidding starts from Dec 22, 2025 and ends on Dec 24, 2025. The allotment for Gujarat Kidney & Super Speciality IPO will be finalized on Dec 26, 2025. Gujarat Kidney & Super Speciality IPO will be listed on BSE, NSE, with a tentative listing date fixed as Dec 30, 2025. The company shall list its equity shares on the BSE, NSE. MUFG Intime India Pvt.Ltd. is the registrar of the issue.

Retail investors can bid for a minimum of 128 shares, extendable to 14,592. S-HNIs will be able to bid for 1,792 shares at ₹2,04,288, while B-HNIs can also apply for a bid of 8,832 shares at ₹10,06,848. The book-running lead manager for the IPO is/are Nirbhay Capital Services Pvt.Ltd..

The total issue ₹250.8 crore, comprising a fresh issue of 2,20,00,000 shares ₹250.8 crore
The Gujarat Kidney & Super Speciality IPO sets its price band at 108-114 for each share. A single application for Gujarat Kidney & Super Speciality Limited IPO must contain at least 128 shares. Sentiment investors need to invest a minimum of 128 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,592 In order to participate in the sNII, investors must purchase at least 14 lots of 1,792 shares for ₹2,04,288, while the bNII requires 69 lots of 8,832 shares for an investment of ₹10,06,848.

Read More
Gujarat Kidney & Super Speciality Valuations
EPS Pre IPO ₹/-
EPS Post IPO ₹/-
ROE 36.61%
ROCE 37.65%
Debt/Equity 0.15
RoNW 36.61%
PAT Margin 23.61%
Price to Book Value 22.62
Market Cap. 898.81 Cr.
Gujarat Kidney & Super Speciality Company Financials
In Crs.
In Cr.
30-Jun-25 31-Mar-25 31-Mar-24 31-Mar-23
Assets 61.59 55.34 20.53 3.87
Revenue 15.27 40.40 5.48 0.00
Profit After Tax 5.40 9.50 1.71 -0.01
Net Worth 30.56 25.71 10.80 0.37
Reserves & Surplus 19.42 14.57 10.60 0.17
Total Borrowing 4.03 3.88 1.94 N/A
About Gujarat Kidney & Super Speciality Company

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispecialty health care service provider engaged in the provision of secondary and tertiary health care services in multiple locations across Gujarat, India.

At the close of business on March 20, 2025, it operates six multispeciality hospitals and three pharmacies, representing a total bed capacity of 400 beds with an approved capacity of 355 beds and an operational capacity of 250 beds.
The hospitals in the company include Gujarat Kidney and Super Speciality Hospital, Vadodara, Gujarat Multispeciality Hospital, Godhra, Raj Palmland Hospital Private Limited, Bharuch, M/s. Surya Hospital and ICU, Borsad, Gujarat Surgical Hospital, Vadodara, and Ashwini Medical Centre, Anand. It also holds a drugstore, Ashwini Medical Store, Anand.

Services:
Secondary Care Services: This refers to both general and surgical treatments.
Tertiary Care Services: Super speciality surgical procedures.

Gujarat Superspeciality Hospital provides medical care in the field of internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. At March 20, 2025, the company had 322 employees, which include 21 full-time Consultants and 32 visiting consultants. At September 30, 2024, the healthcare professionals of the company comprised 47 doctors and 138 nurses.

Read More
Gujarat Kidney & Super Speciality - Promoter(s)

Dr. Pragnesh Yashwantsinh Bharpoda

Dr. Bhartiben Pragnesh Bharpoda

Dr. Yashwantsingh Motisinh Bharpoda

Anitaben Yashwantsinh Bharpoda

Pre Issue Share Holding : 99.10%

Post Issue Share Holding : 71.45%

Gujarat Kidney & Super Speciality IPO - Issue Objectives
1

Proposed acquisition of Parekhs Hospital at Ahmedabad.

2

Part-payment of purchase consideration for the already acquired Ashwini Medical Centre

3

Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara.

4

Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location.

5

Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company

6

Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda

Strength
Expertise in Kidney Sciences: The company has developed expertise in kidney sciences with sub-specialties in kidney diseases. This has been made possible by the multispecialty hospitals providing tertiary care.
Asset-Light Hospital Model of Operation: The hospitals are operated through leasing and majority-control companies so that assets do not serve as growth barriers by requiring significant investment in land and medical assets.
Ability to Attract and Retain Skilled Medical Talent: The low rate of staff turnover in doctors and nurses indicates that the company is able to attract and retain the best medical talent using the multidisciplinary and high-volume delivery system.
Weakness
Risks Relating to Proposed Acquisition of Parekhs Hospital: The proposed use of issue proceeds involves acquiring a 100% stake in Parekhs Hospital Private Limited. If any issue arises that prevents them from carrying out this proposed acquisition, this could pose a threat to their future business activities.
Funding Risk regarding Acquisition of Ashwini Medical Centre: The issue expenses are partly intended to be utilized for the partial payment of the already acquired Ashwini Medical Centre. This may create a hindrance in the funding aspect of the company.
Risk of Execution and Approvals in New Hospital Expansion: The proposed establishment of a woman’s healthcare hospital in the city of Vadodara faces risks in terms of delays in approvals, acquisition of capital equipment, rising costs due to inflation, and lease issues.
Contact Details

Gujarat Kidney & Super Speciality

Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara, Gujarat, India Vadodara, Gujarat, 390020

+91 265 298 48

info@gujaratsuperspecialityhospital.com

http://www.gujaratsuperspecialityhospital.com/

Registrar Contact Details

MUFG Intime India Private Limited (Link Intime)

+91-22-4918 6270

gujaratkidney.ipo@in.mpms.mufg.com

https://in.mpms.mufg.com/Initial_Offer/public-issues.html